MMP2 and colorectal carcinoma: The inhibition of MMP-2 and MMP-9 is considered a promising therapeutic strategy in CRC and other kinds of cancer [39] and can elicit significant consequences such as reducing tumor growth and angiogenesis, limiting invasion and metastasis, improving clinical outcomes, overcoming resistance mechanisms, and possibility for combinatorial treatment strategy [40].